Edition:
United States

Imv Inc (IMV.TO)

IMV.TO on Toronto Stock Exchange

6.31CAD
18 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.31
Open
$6.16
Day's High
$6.40
Day's Low
$6.16
Volume
23,200
Avg. Vol
43,205
52-wk High
$9.49
52-wk Low
$3.33

Chart for

About

Imv Inc, formerly known as Immunovaccine Inc is a Canada-based clinical-stage immuno oncology company. The Company develops products based on its vaccine enhancement platform with a primary focus on T lymphocytes (T cell) activating therapies for cancer. The Company's DepoVax adjuvanting/delivery platform produces immune... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $139.19
Shares Outstanding(Mil.): 127.70
Dividend: --
Yield (%): --

Financials

  IMV.TO Industry Sector
P/E (TTM): -- 85.36 32.76
EPS (TTM): -0.09 -- --
ROI: -73.34 2.21 14.61
ROE: -125.02 3.85 16.34

BRIEF-Immunovaccine Announces $12.5 Million Bought Deal Offering

* IMMUNOVACCINE INC - ENTERED INTO BOUGHT DEAL FINANCING AGREEMENT TO SELL 6.3 MILLION COMMON SHARES AT A PRICE OF $2.00 PER COMMON SHARE Source text for Eikon: Further company coverage:

Jan 25 2018

Earnings vs. Estimates